Pramiracetam

Pramiracetam is fat-soluble and should be taken with dietary fats for optimal absorption. Never administer sublingually, as this can cause painful chemical burns. The compound is marketed as a prescription drug in parts of Europe for treating memory deficits in aging populations with neurodegenerative disorders. In the United States, it is available as a dietary supplement. Use precise measurement scales for dosing, and consider supplementing with a choline source to enhance effects and reduce the likelihood of headaches.

Also known as: Remen, Ci-879, Pramistar, Neupramir

Classification

Chemical: Racetam
Psychoactive: Nootropic
Psychoactive: Stimulant
Tag: Cognitive-enhancer
Tag: Research-Chemical

Effects

Stimulation
Headache
Increased Heart Rate
Stamina Enhancement
Subtle Stimulation
Gastrointestinal Distress
Focus Enhancement
Memory Enhancement
Emotion Suppression
Mindfulness
Wakefulness
Thought Connectivity
Visual Acuity Enhancement
Auditory Acuity Enhancement
Color Enhancement
Light Sensitivity
Appetite Suppression
Bodily Control Enhancement

Routes of Administration

Oral

Dosage

Threshold: 100 mg
Light: 250-500 mg
Common: 400-1200 mg
Strong: 800-1200 mg
Heavy: 1200 mg

Duration

Onset: 0.5-1.5 h
Peak: 2-3 h
Offset: 2-4 h
After Effects: 6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu